{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Regional+block", "query": { "intervention": "Regional block" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 626, "total_pages": 63, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Regional+block&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-11T21:15:23.343Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02276495", "title": "Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain Management" ], "interventions": [ { "name": "ACB Control - 20 ml saline injection for ACB", "type": "OTHER" }, { "name": "ACB Study - 20 ml 0.5% Ropivacaine for Adductor Canal Block", "type": "DRUG" }, { "name": "Local infiltration - 100 mLs of a solution containing: Ropivacaine + Epinephrine + Ketorolac + Clonidine + 0.9% Normal saline", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "University of California, Irvine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 55, "start_date": "2015-01-01", "completion_date": "2024-09-30", "has_results": true, "last_update_posted_date": "2024-10-29", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02276495" }, { "nct_id": "NCT04445337", "title": "Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COVID 19", "ARDS" ], "interventions": [ { "name": "Stellate Ganglion Block", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Nebraska", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "19 Years to 85 Years" }, "enrollment_count": 1, "start_date": "2020-11-15", "completion_date": "2021-11-01", "has_results": true, "last_update_posted_date": "2025-01-20", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04445337" }, { "nct_id": "NCT04766996", "title": "PROUD Study - Preventing Opioid Use Disorders", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Anesthesia", "Opioid Use" ], "interventions": [ { "name": "Guided mindfulness exercises", "type": "BEHAVIORAL" }, { "name": "Self-administered aromatherapy", "type": "OTHER" }, { "name": "Baby aspirin", "type": "DRUG" }, { "name": "Tylenol/Acetaminophen", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Meloxicam", "type": "DRUG" }, { "name": "Prilosec", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Voltaren", "type": "DRUG" }, { "name": "Zofran", "type": "DRUG" }, { "name": "Pepcid", "type": "DRUG" }, { "name": "Reglan", "type": "DRUG" }, { "name": "Versed", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Propofol", "type": "DRUG" }, { "name": "Ancef", "type": "DRUG" }, { "name": "Tranexamic Acid (TXA)", "type": "DRUG" }, { "name": "Decadron", "type": "DRUG" }, { "name": "Bupivacaine hydrochloride", "type": "DRUG" }, { "name": "Toradol", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "OTHER", "DRUG" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2021-05-17", "completion_date": "2021-12-27", "has_results": true, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04766996" }, { "nct_id": "NCT00923598", "title": "Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Total Knee Arthroplasty", "Knee Pain" ], "interventions": [ { "name": "0.1% and 0.4% perineural ropivicaine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2009-06", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2019-12-02", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00923598" }, { "nct_id": "NCT07672301", "title": "Total Intravenous Anesthesia vs Spinal Anesthesia in Patients Undergoing Unilateral Primary Total Knee Arthroplasty", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Total Knee Arthroplasty (TKA)" ], "interventions": [ { "name": "Total IntraVenous Anesthesia (TIVA)", "type": "COMBINATION_PRODUCT" }, { "name": "Spinal-Block", "type": "COMBINATION_PRODUCT" }, { "name": "Electroencephalogram (EEG)", "type": "DEVICE" } ], "intervention_types": [ "COMBINATION_PRODUCT", "DEVICE" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2026-03-11", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-06-26", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07672301" }, { "nct_id": "NCT05323175", "title": "Erector Spinae Plane (ESP) Block for Renal Colic", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Renal Colic" ], "interventions": [ { "name": "Ropivacaine injection", "type": "DRUG" }, { "name": "Standard of care medications", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Stony Brook University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 24, "start_date": "2022-04-25", "completion_date": "2026-01-09", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 1, "location_summary": "Stony Brook, New York", "locations": [ { "city": "Stony Brook", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05323175" }, { "nct_id": "NCT06340932", "title": "Impact of Opioid Avoidance Protocol for ACL Reconstruction", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "ACL Tear", "Post Operative Pain" ], "interventions": [ { "name": "Iovera", "type": "DEVICE" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Bupivacaine Hydrochloride", "type": "DRUG" }, { "name": "Acetaminophen 500Mg Cap", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Matthew Varacallo", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 32, "start_date": "2024-04-27", "completion_date": "2025-02-01", "has_results": false, "last_update_posted_date": "2025-03-07", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 1, "location_summary": "DuBois, Pennsylvania", "locations": [ { "city": "DuBois", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06340932" }, { "nct_id": "NCT05698576", "title": "TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prostate Cancer", "Adverse Effects Surgery", "MRI", "Ultrasound", "Sexual Function Disturbances", "Urinary Incontinence", "Urinary Function Disorders", "Prostate Biopsy", "Ablation" ], "interventions": [ { "name": "TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of Prostate Cancer (TPF-LITT)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Urological Research Network, LLC", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "80 Years", "sex": "MALE", "summary": "50 Years to 80 Years · Male only" }, "enrollment_count": 20, "start_date": "2022-03-16", "completion_date": "2033-01-30", "has_results": false, "last_update_posted_date": "2023-01-26", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 1, "location_summary": "Hialeah, Florida", "locations": [ { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05698576" }, { "nct_id": "NCT00135889", "title": "Continuous Femoral Nerve Block Following Total Knee Replacement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Femoral perineural infusion", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of General Medical Sciences (NIGMS)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 50, "start_date": "2005-01", "completion_date": "2008-07", "has_results": false, "last_update_posted_date": "2009-10-08", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 2, "location_summary": "La Jolla, California • Gainesville, Florida", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00135889" }, { "nct_id": "NCT05497453", "title": "A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hepatocellular Carcinoma", "Solid Tumor", "Hepatocellular Carcinoma Non-resectable", "Hepatocellular Carcinoma Recurrent", "Hepatocellular Cancer", "Liver Cancer", "Liver, Cancer Of, Non-Resectable" ], "interventions": [ { "name": "OTX-2002", "type": "DRUG" }, { "name": "Tyrosine kinase inhibitor One", "type": "DRUG" }, { "name": "Tyrosine kinase inhibitor Two", "type": "DRUG" }, { "name": "Checkpoint Inhibitor, Immune", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Omega Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2022-08-19", "completion_date": "2024-11-21", "has_results": false, "last_update_posted_date": "2025-02-03", "last_synced_at": "2026-09-11T21:15:23.343Z", "location_count": 6, "location_summary": "Duarte, California • Gainesville, Florida • Chicago, Illinois + 3 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT05497453" } ] }